Henry Schein (NASDAQ:HSIC – Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 4.800-4.940 for the period, compared to the consensus estimate of 4.970. The company issued revenue guidance of $12.4 billion-$13.2 billion, compared to the consensus revenue estimate of $13.2 billion.
Analyst Ratings Changes
HSIC has been the topic of a number of research reports. Jefferies Financial Group raised their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective on the stock. Barrington Research raised their price objective on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, January 30th. Finally, Mizuho initiated coverage on Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective on the stock. Eight equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and an average target price of $80.09.
Check Out Our Latest Report on Henry Schein
Henry Schein Price Performance
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles
- Five stocks we like better than Henry Schein
- What is a Stock Market Index and How Do You Use Them?
- Rivian’s Rough Patch: Is the Dip a Doorway to Long-Term Gains?
- What Are Treasury Bonds?
- Institutions Signal Opportunty to Buy High-Yield Kraft-Heinz
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Explosive Tech Stocks Breaking Out Right Now
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.